Abstract 1325
Case Summary
A 79-year-old woman was treated in our ward for an invasive carcinoma of no special type (NST) of her left breast, discovered by a spontaneous apparition of a localized ecchymotic lesion of the breast. The unique calling-spot was this 4x5cm homogeneous oval shape purpura without any notion of trauma, stable for months. The patient have no medical history of thrombopenia nor allergies. The physical exam was poor, without any palpable breast lesion. A not well defined solid para-areolar structure of 11 mm was found during the senological assessment. Biopsies were performed and highlighted a grade II NST, triple negative, Ki67 15%. The axillary cytology was positive. Subsequently this atypical presentation, a punch biopsy was performed on the ecchymosis. The histology showed the presence of dermal lymphatic carcinomatous emboli that may correspond to a mammary origin, and blood extravasations in the dermis, explaining the ecchymotic aspect. The PET-CT was negative. Neo-adjuvant chemotherapy was decided before mastectomy and axillary dissection. This was a rare clinical presentation of a locally advanced breast cancer without any reported similar case. Usually, the presence of emboli with carcinoma cells obstructing lymph ducts is associated with an inflammatory breast cancer. The presence of tumor emboli in the lymph ducts comes out in favor of the diagnosis but it is not mandatory. Moreover, dermal lymphatic invasion without typical clinical presentation isn’t sufficient to diagnose a carcinomatous mastitis. A main criterion is the rapidity of the worsening of the symptoms which is not obvious in that case with a stagnation of the skin lesion for months. The skin lesion of our patient could be suspected of being a mammary angiosarcoma. This possibility was quickly put aside with the absence of vascular tumoral proliferation on the biopsies. Every acute purpura is a serious condition to diagnose in emergency to not miss a meningococcemia, a severe thrombopenia or an infective endocarditis. Any isolated purpura of the breast must set off a senological assessment and cutaneous biopsies, when the clinical presentation is atypical and in absence of patent diagnosis, in order not to miss an underlying, locally advanced neoplasia.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
905 - Dose distribution in coronary arteries in left-sided breast cancer treated with Radiotherapy
Presenter: Umesh Velu
Session: Poster display - Cocktail
Resources:
Abstract
1060 - Metabolic Syndrome in Luminal-Type Non-Metastatic Breast Cancer during Hormonal Treatment Does it really have impact on prognosis?
Presenter: Kartika Taroeno-Hariadi
Session: Poster display - Cocktail
Resources:
Abstract
1148 - High Eosinophils Lymphocyte Ratio (ELR) Related With Subtype of Breast Cancer in Sanglah General Hospital, Bali
Presenter: Anak Agung Lestari
Session: Poster display - Cocktail
Resources:
Abstract
400 - Ribociclib (RIB) + endocrine therapy (ET) in Japanese women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC)
Presenter: Norikazu Masuda
Session: Poster display - Cocktail
Resources:
Abstract
801 - Osteopontin Level and Promoter Polymorphism is Associated with Aggressiveness in Breast Cancer
Presenter: Mohamed Elbaiomy
Session: Poster display - Cocktail
Resources:
Abstract
1014 - Global Clinical Trials Validating Bioequivalence with China-Manufactured Trastuzumab Biosimilar, HLX02, and Herceptin®
Presenter: Quanying Zhang
Session: Poster display - Cocktail
Resources:
Abstract
1138 - Circular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s
Presenter: Yunjie He
Session: Poster display - Cocktail
Resources:
Abstract
145 - Repeat biopsy a must in recurrent breast cancer: A study from tertiary cancer centre in India.
Presenter: Abhishek Anand
Session: Poster display - Cocktail
Resources:
Abstract
804 - Meta-analysis of four Phase 3 RCTs of tamoxifen, versus 3rd generation aromatase inhibitors as 1st Line Endocrine Therapy for HR+ Advanced Breast Cancer
Presenter: John Robertson
Session: Poster display - Cocktail
Resources:
Abstract
1154 - Estimation of efficacy and safety of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients
Presenter: Sung Soo Kang
Session: Poster display - Cocktail
Resources:
Abstract